In Depth 10 Sep 2025 When rare diseases are not so rare after all: A closer look at where and why this happens Discover how in some communities around the world, the prevalence of rare diseases is higher due to factors like cousin marriages. September 10, 2025 - 12 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 9 Sep 2025 Top biotech deals in August 2025 Discover the top biotech deals of August 2025, as several big pharmas shopped around, especially in the field of small molecules. September 9, 2025 - 7 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Sponsored by Lonza 9 Sep 2025 Advanced expression vector design to overcome challenges in developing multichain biotherapeutics Learn how multichain biotherapeutics like bispecific antibodies and Fc-fusion proteins overcome manufacturing challenges with advanced vectors and expression systems. September 9, 2025 - 8 minutesmins - By Jennifer Tsang Share WhatsApp Twitter Linkedin Email
News and Trends 8 Sep 2025 With Lykos CRL now public, FDA opens new era of accountability As the release of a CRL declining Lykos’ therapy generates a strong reaction from MAPS, delve into what this new transparency could change. September 8, 2025 - 8 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 5 Sep 2025 Closing treatment gaps in yellow fever: are germ-free egg-based vaccines the answer? Germ-free egg-based vaccines could be the answer to curbing yellow fever outbreaks. September 5, 2025 - 7 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Podcast 5 Sep 2025Navigating the biotech development journey from first steps to global scale with Lonza Our guests Alice Harrison and Megan Mason from Lonza discuss how the company is helping innovators develop and scale their therapies. September 5, 2025 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
Interview 3 Sep 2025 Radiopharma’s big year: Interview with RadioMedix CEO Dr. Delpassand As radiopharma is gaining momentum, read our interview with Dr. Delpassand, the CEO of RadioMedix’s, an established company of the field. September 3, 2025 - 12 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 3 Sep 2025 How are biotechs tackling malaria? As a recent approval closes a major therapeutic gap, let’s take a look at some of the latest progress and new treatments against malaria. September 3, 2025 - 13 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 2 Sep 2025 The biggest biotech funding rounds in August 2025 Kriya Therapeutics, Strand Therapeutics, and Minghui Pharmaceutical bagged the biggest biotech funding rounds overall in August 2025. September 2, 2025 - 4 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 1 Sep 2025 Blood Cancer Awareness Month: What biotech holds in store As September marks the beginning of Blood Cancer Awareness Month, delve into what is being developed in the biotech pipelines. September 1, 2025 - 13 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Webinars 1 Sep 2025Organoids in cancer research: Paving the way for faster drug development across cancer indications Discover how patient-derived organoids enable smarter, quicker oncology drug development. September 1, 2025 Share WhatsApp Twitter Linkedin Email
In Depth 29 Aug 2025 Can genetically modified crops help us adapt to climate change? Find out whether genetically modified crops can help us adapt to climate change and ensure global food security. August 29, 2025 - 14 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email